Indeed, F. nucleatum can target the TLR4 and myeloid differential protein-88 (MyD88) innate immune signaling with specific microRNAs to activate the autophagy pathway, leading to different CRC chemotherapeutic response to promote CRC resistance to chemotherapy (Figure 1c) [76]. The gene discussed is MYD88; the disease is colorectal carcinoma.